Investing Profile

Eric Aguiar

VC
Photo of Eric Aguiar, Partner at Aisling Capital

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
9
$280M
CompanyStageDateRound SizeTotal Raised
Garuda Therapeutics
Series BFeb 2023$62M
Series ASep 2021$72M
$130M
Co-investors: Carl Gordon (OrbiMed), Shaan C. Gandhi (Northpond Ventures)
Eidos Therapeutics
Series BApr 2018$64M
$64M
Co-investors: Rajeev Shah (RA Capital)
Bristol-Myers Squibb
Post Ipo EquityFeb 2017$80M
$80M
Co-investors: Albert Cha (Frazier Healthcare Partners), Peter Kolchinsky (RA Capital), Gregory Bailey
Invitae
Series FOct 2014$120M
$160M
Co-investors: Anya Schiess (J.P. Morgan Chase & Co.), Randy Scott (HealthQuest Capital)
Intuity Medical
Series DJan 2010$64M
$220M
Co-investors: Anders Hove (Acorn Bioventures), Casey Tansey (U.S. Venture Partners (USVP)), Scott Bluestein (Hercules Capital)
Cardiokine
Series BMay 2006$50M
Series AApr 2004$37M
$87M
3-Dimensional Pharmaceuticals
Series UnknownFeb 1997$14M
$14M
Partner Thomas, McNerney and PartnersPresent
Partner Aisling Capital2016 - Present